Users Coming Off Slimming Injections Put On Weight Four Times Faster Compared to Those on Conventional Diets

Illustration of pharmaceutical injection and weighing machine
Obesity treatment often requires long-term strategies.

A recent study reveals that individuals who come off blockbuster slimming jabs like Wegovy and Mounjaro tend to recover lost weight at a significantly accelerated pace than those who halt traditional lifestyle regimens.

Findings released in a major medical journal shows that while obese people frequently drop substantial amounts of their total mass while on the medication, the mass comes back at an estimated rate of nearly a kilo each month once they quit.

"Users using such treatments should be cognizant of the risk of quick rebound weight gain when the therapy ends," warns expert Dr. Susan Jebb.

Such speed of regain means a reversion to original mass in about 18 months.

Comparing Therapies

The analysis, which reviewed 37 of studies involving over 9,000 of patients, contrasted the effects of these new drugs with older methods.

Scientists point out that people who shed pounds through diet and exercise usually see a slower creep back—around 0.1 kg a month—post-intervention.

Understanding the Quick Regain

Nutrition scientists suggest the mechanism of the drugs accounts for the heightened regain.

These medications imitate a natural hormone called GLP-1, which moderates hunger.

"Sustained high doses of the hormone levels far above than the body's typical production may cause the body to generate a reduced amount of its endogenous GLP-1, and may also reduce sensitivity to its actions," explained Dr. Adam Collins, a nutrition researcher.

"Stopping of this medication results in hunger is unsuppressed, making binge eating far more likely."

An Ongoing Condition?

Health authorities recommend the jabs for individuals with obesity-related medical conditions, alongside recommended lifestyle changes.

Professionals say that, due to the high risk of relapse, the therapy is often life-long.

This perspective is echoed by pharmaceutical companies, who state that the results "underscore the persistent nature of obesity," similar to managing diseases like hypertension.

Patient Experiences

Individuals who have discontinued the jabs report a sudden return of cravings.

"I experienced something flipping and you become ravenous," recalled one woman.

The struggle is exacerbated if patients have not developed permanent dietary or behavioural changes during treatment.

Significant Use

Survey data show that a significant number of people in the UK have tried these injections in the last 12 months, with demand remaining high.

  • Use is higher among females compared to men.
  • The 40s and 50s demographic shows the greatest usage rates.
  • Many obtain the medications through private prescriptions rather than the NHS.

In conclusion, experts emphasize that while the jabs are potent agents for shedding pounds, they are not a permanent solution and lasting health benefits relies on ongoing lifestyle changes.

Edward Riley
Edward Riley

A lottery enthusiast and analyst with over a decade of experience in UK gaming trends and strategies.